General Information of Drug Off-Target (DOT) (ID: OT4BHUGQ)

DOT Name Acetylcholinesterase collagenic tail peptide (COLQ)
Synonyms AChE Q subunit; Acetylcholinesterase-associated collagen
Gene Name COLQ
Related Disease
Atopic dermatitis ( )
Congenital myasthenic syndrome 5 ( )
Diverticulitis ( )
Esophageal adenocarcinoma ( )
Esophageal squamous cell carcinoma ( )
Fibrosarcoma ( )
Gastric adenocarcinoma ( )
Neoplasm ( )
Rheumatoid arthritis ( )
Syndactyly-telecanthus-anogenital and renal malformations syndrome ( )
Isolated congenital microcephaly ( )
Respiratory failure ( )
Alzheimer disease ( )
Congenital myasthenic syndrome ( )
Dementia ( )
Nasopharyngeal carcinoma ( )
UniProt ID
COLQ_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1VZJ
Pfam ID
PF01391
Sequence
MVVLNPMTLGIYLQLFFLSIVSQPTFINSVLPISAALPSLDQKKRGGHKACCLLTPPPPP
LFPPPFFRGGRSPLLSPDMKNLMLELETSQSPCMQGSLGSPGPPGPQGPPGLPGKTGPKG
EKGELGRPGRKGRPGPPGVPGMPGPIGWPGPEGPRGEKGDLGMMGLPGSRGPMGSKGYPG
SRGEKGSRGEKGDLGPKGEKGFPGFPGMLGQKGEMGPKGEPGIAGHRGPTGRPGKRGKQG
QKGDSGVMGPPGKPGPSGQPGRPGPPGPPPAGQLIMGPKGERGFPGPPGRCLCGPTMNVN
NPSYGESVYGPSSPRVPVIFVVNNQEELERLNTQNAIAFRRDQRSLYFKDSLGWLPIQLT
PFYPVDYTADQHGTCGDGLLQPGEECDDGNSDVGDDCIRCHRAYCGDGHRHEGVEDCDGS
DFGYLTCETYLPGSYGDLQCTQYCYIDSTPCRYFT
Function Anchors the catalytic subunits of asymmetric AChE to the synaptic basal lamina.
Tissue Specificity Found at the end plate of skeletal muscle.

Molecular Interaction Atlas (MIA) of This DOT

16 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Atopic dermatitis DISTCP41 Strong Genetic Variation [1]
Congenital myasthenic syndrome 5 DISJRCI1 Strong Autosomal recessive [2]
Diverticulitis DIS1AK7Q Strong Genetic Variation [3]
Esophageal adenocarcinoma DISODWFP Strong Genetic Variation [4]
Esophageal squamous cell carcinoma DIS5N2GV Strong Biomarker [4]
Fibrosarcoma DISWX7MU Strong Biomarker [5]
Gastric adenocarcinoma DISWWLTC Strong Biomarker [6]
Neoplasm DISZKGEW Strong Biomarker [5]
Rheumatoid arthritis DISTSB4J Strong Biomarker [7]
Syndactyly-telecanthus-anogenital and renal malformations syndrome DISZA8BN Strong Genetic Variation [8]
Isolated congenital microcephaly DISUXHZ6 moderate Biomarker [9]
Respiratory failure DISVMYJO moderate Genetic Variation [9]
Alzheimer disease DISF8S70 Limited Genetic Variation [10]
Congenital myasthenic syndrome DISJLG2T Limited Biomarker [11]
Dementia DISXL1WY Limited Biomarker [10]
Nasopharyngeal carcinoma DISAOTQ0 Limited Biomarker [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 16 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [13]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [14]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [15]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [16]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [17]
KOJIC ACID DMP84CS Investigative KOJIC ACID increases the expression of Acetylcholinesterase collagenic tail peptide (COLQ). [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 Investigation of the eotaxin gene -426C-->T, -384A-->G and 67G-->a single-nucleotide polymorphisms and atopic dermatitis in Italian children using family-based association methods.Clin Exp Dermatol. 2008 May;33(3):316-21. doi: 10.1111/j.1365-2230.2007.02672.x. Epub 2008 Feb 28.
2 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
3 Sequence variants in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis.Nat Commun. 2017 Jun 6;8:15789. doi: 10.1038/ncomms15789.
4 Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.Mol Cancer. 2018 Feb 19;17(1):54. doi: 10.1186/s12943-018-0790-4.
5 IFN- is required for cytotoxic T cell-dependent cancer genome immunoediting.Nat Commun. 2017 Feb 24;8:14607. doi: 10.1038/ncomms14607.
6 Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.Tumour Biol. 2015 Nov;36(11):8247-57. doi: 10.1007/s13277-015-3972-3. Epub 2015 Sep 14.
7 Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.Scand J Clin Lab Invest. 2019 Feb-Apr;79(1-2):7-16. doi: 10.1080/00365513.2018.1550807. Epub 2019 Feb 6.
8 CMS HCC risk scores and home health patient experience measures.Am J Manag Care. 2018 Oct 1;24(10):e319-e324.
9 COLQ-mutant Congenital Myasthenic Syndrome with Microcephaly: A Unique Case with Literature Review.Transl Neurosci. 2017 Jul 20;8:65-69. doi: 10.1515/tnsci-2017-0011. eCollection 2017.
10 CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.Neurobiol Aging. 2017 Nov;59:1-9. doi: 10.1016/j.neurobiolaging.2017.06.028. Epub 2017 Jul 11.
11 Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.J Clin Neurosci. 2020 Feb;72:468-471. doi: 10.1016/j.jocn.2019.12.007. Epub 2019 Dec 10.
12 Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.
13 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
14 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
15 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
16 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
17 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
18 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.